glp 1 effect on cholesterol A schematic graph of the mechanism. GLP-1 induces AMPK and LXR-mediated Potential of Glucagon-Like Peptide 1

T.WstR

10.1021/jacs.8b09913 J

Subcutaneous delivery suits both peptides: it gives a smooth absorption curve that fits the once-daily, pulse-timed design, and it keeps the injection itself low-volume at roughly a tenth of a millilitre

Thiazolidinediones (TZDs) (such as pioglitazone and rosiglitazone) enhance insulin sensitivity in skeletal muscle, liver, and adipose tissue and promote fat redistribution from liver and skeletal muscle to adipocytes [159]

Trends Endocrinol Metab 20, 436443, 10.1016/j.tem.2009.05.008 (2009)

For example, tirzepatide, a dual GLP-1 and GIP agonist, is FDA-approved under the brand name Zepbound specifically for chronic weight management in adults with obesity or overweight and at least one weight-related condition